About Medirio

About company

Medirio provides insulin pen users with a new drug delivery system which allows diabetic patients to manage their insulin injections in an easier, discreet and more comfortable way. Their medical device is indeed designed to significantly improve both efficiency and therapy control, together with a fresh new user experience which eases and simplifies the medication‑related action plan. The integrated insulin delivery system eliminates all of the complicating factors associated with insulin pens or syringes. They managed to develop a drug delivery system that is so small and lightweight. Medirio was founded in 2013 and is based in Sierre, Valais, Switzerland.